Avidity Partners Management Lp

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Dianthus Therapeutics, Inc.
DNTH
$81.53M9.262.72M+123.2%+$45M2.96
Fusion Pharmaceuticals Inc.
FUSN
$138.59M7.646.5M0%+$05.03
Caribou Biosciences, Inc.
CRBU
$29.74M6.415.79M-9.04%-$2.95M1.08
Jasper Therapeutics, Inc.
JSPR
$22.31M5.04760,000New+$22.31M0.81
Arvinas, Inc.
ARVN
$123.23M4.362.99M+<0.01%+$3,013.444.47
Neurogene Inc.
NGNE
$23.68M3.58465,237-0.22%-$51,205.400.86
Phathom Pharmaceuticals, Inc.
PHAT
$18.43M2.961.74M+0.78%+$142,520.400.67
Syndax Pharmaceuticals, Inc.
SNDX
$57.42M2.842.41M-38.92%-$36.59M2.08
REGENXBIO Inc.
RGNX
$27.39M2.641.3MNew+$27.39M0.99
Mirum Pharmaceuticals, Inc.
MIRM
$28.71M2.421.14M0%+$01.04
CG Oncology, Inc. Common stock
CGON
$63.86M2.181.45MNew+$63.86M2.32
Structure Therapeutics Inc.
GPCR
$37.03M1.85864,000-20%-$9.26M1.34
Immunome, Inc.
IMNM
$21.57M1.46873,891-34.47%-$11.34M0.78
Surgery Partners, Inc.
SGRY
$43.1M1.141.45M+23.93%+$8.32M1.56
Rocket Pharmaceuticals, Inc.
RCKT
$27.61M1.131.02M-40.38%-$18.7M1
Neumora Therapeutics, Inc. Common Stock
NMRA
$24.75M1.131.8M-9.58%-$2.62M0.9
Ultragenyx Pharmaceutical Inc.
RARE
$43.59M1.12933,500+10.54%+$4.16M1.58
Acadia Healthcare Company, Inc.
ACHC
$79.62M1.081M-13.11%-$12.02M2.89
IDEAYA Biosciences, Inc.
IDYA
$35.09M1.06799,700-47.39%-$31.61M1.27
Xenon Pharmaceuticals Inc.
XENE
$30.57M0.94710,000-12.99%-$4.56M1.11
Jazz Pharmaceuticals plc
JAZZ
$70.33M0.93584,000+19.4%+$11.43M2.55
Axsome Therapeutics, Inc.
AXSM
$34.39M0.91431,000-6.18%-$2.27M1.25
Lantheus Holdings, Inc.
LNTH
$29.88M0.69480,000+26.32%+$6.22M1.08
Blueprint Medicines Corporation
BPMC
$40.41M0.68426,000-30.73%-$17.93M1.47
Apogee Therapeutics, Inc.
APGE
$25.58M0.66384,893New+$25.58M0.93
Natera, Inc.
NTRA
$73.47M0.65803,300-27.63%-$28.05M2.67
Tenet Healthcare Corporation
THC
$63.17M0.62601,000-31%-$28.38M2.29
Immunocore Holdings plc
IMCR
$18.62M0.57286,400-4.6%-$897,000.000.68
Intra-Cellular Therapies, Inc.
ITCI
$41.52M0.57600,000-15.49%-$7.61M1.51
Neurocrine Biosciences, Inc.
NBIX
$73.99M0.53536,500-18.46%-$16.76M2.69
United Therapeutics Corporation
UTHR
$49.85M0.49217,000-8.52%-$4.64M1.81
Glaukos Corporation
GKOS
$21.12M0.45224,000New+$21.12M0.77
Avantor, Inc.
AVTR
$68.91M0.42.69M+27.01%+$14.66M2.5
Revolution Medicines, Inc.
RVMD
$20.47M0.39635,000+958.33%+$18.53M0.74
Legend Biotech Corporation
LEGN
$37.48M0.37668,300-2.44%-$936,703.001.36
Illumina, Inc.
ILMN
$63.73M0.29464,100New+$63.73M2.31
Vaxcyte, Inc.
PCVX
$19.4M0.26284,000-50.19%-$19.55M0.7
Align Technology, Inc.
ALGN
$61.98M0.25189,000+21.31%+$10.89M2.25
Alnylam Pharmaceuticals, Inc.
ALNY
$36.32M0.19243,000New+$36.32M1.32
Boston Scientific Corporation
BSX
$133.97M0.131.96M+3.49%+$4.52M4.86
Cigna Corporation
CI
$67.01M0.07184,500New+$67.01M2.43
Intuitive Surgical, Inc.
ISRG
$90.19M0.06226,000+165.88%+$56.27M3.27
Regeneron Pharmaceuticals, Inc.
REGN
$65.45M0.0668,0000%+$02.38
DexCom, Inc.
DXCM
$24.54M0.04176,900New+$24.54M0.89
CVS Health Corporation
CVS
$43.47M0.04545,000-26.35%-$15.55M1.58
Merck & Co., Inc.
MRK
$66.24M0.02502,000New+$66.24M2.4
Danaher Corporation
DHR
$35.91M0.02143,800-50.41%-$36.51M1.3
AbbVie Inc.
ABBV
$41.34M0.01227,000-20.18%-$10.45M1.5
Thermo Fisher Scientific Inc.
TMO
$21.27M0.0136,600-79.96%-$84.86M0.77
Eli Lilly and Company
LLY
$54.46M0.0170,000-17.65%-$11.67M1.98